BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15778731)

  • 1. Allogeneic transplantation for hepatosplenic alphabeta T-cell lymphoma.
    Mansour MR; Dogan A; Morris EC; Khwaja A; Linch DC; Mackinnon S; Peggs KS
    Bone Marrow Transplant; 2005 May; 35(9):931-4. PubMed ID: 15778731
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful allogeneic bone marrow transplantation for hepatosplenic gammadelta T cell lymphoma.
    Ooi J; Iseki T; Adachi D; Yamashita T; Tomonari A; Tojo A; Tani K; Asano S
    Haematologica; 2001 Oct; 86(10):E25. PubMed ID: 11602432
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatosplenic T-cell lymphoma and TNF-α inhibitors.
    Pozadzides JV; Pro B
    Expert Rev Hematol; 2009 Dec; 2(6):611-4. PubMed ID: 21082951
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatosplenic T-cell lymphoma: clinicopathologic, immunophenotypic, and molecular characterization of 17 Chinese cases.
    Lu CL; Tang Y; Yang QP; Wang M; Zhao S; Bi CF; Jiang NG; Zhang WY; Liu JP; Xu X; Liu WP
    Hum Pathol; 2011 Dec; 42(12):1965-78. PubMed ID: 21683978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatosplenic αβ T-cell lymphoma arising after long-term azathioprine therapy successfully treated with allogeneic bone marrow transplant.
    Bašić Kinda S; Duraković N; Dotlić S; Serventi Seiwerth R; Davidović Mrsić S; Dubravčić K; Aurer I
    Leuk Lymphoma; 2013 Jun; 54(6):1334-5. PubMed ID: 23083012
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatosplenic alphabeta T-cell lymphoma successfully treated with allogeneic bone marrow transplantation.
    Machino T; Okoshi Y; Kaneko S; Obara N; Mukai HY; Suzukawa K; Hasegawa Y; Yamashita Y; Mori N; Kojima H; Nagasawa T
    Bone Marrow Transplant; 2007 Apr; 39(8):513-4. PubMed ID: 17310131
    [No Abstract]   [Full Text] [Related]  

  • 7. Gastroenterology: Hepatosplenic T cell lymphoma associated with schistosomiasis.
    Azevedo P; Pedrosa MS; Resende V
    J Gastroenterol Hepatol; 2015 Sep; 30(9):1333. PubMed ID: 26211690
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment with reduced-intensity cord blood transplant in a patient with relapsed refractory hepatosplenic T-cell lymphoma.
    Sumi M; Takeda W; Kaiume H; Kirihara T; Kurihara T; Sato K; Ueki T; Hiroshima Y; Ueno M; Ichikawa N; Kobayashi H
    Leuk Lymphoma; 2015 Apr; 56(4):1140-2. PubMed ID: 25065703
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravascular lymphomatosis in T-hepatosplenic lymphoma.
    Suarez-Vilela D; Izquierdo-Garcia FM; Ramos-Ortega F
    Am J Clin Pathol; 2002 Apr; 117(4):662-3. PubMed ID: 11939744
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatosplenic gamma-delta T-cell lymphoma.
    Ferreri AJ; Govi S; Pileri SA
    Crit Rev Oncol Hematol; 2012 Aug; 83(2):283-92. PubMed ID: 22047938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of hepatosplenic T cell lymphoma in an adolescent with Turner syndrome using ifosfamide, carboplatin, and etoposide followed by allogeneic hematopoietic stem cell transplant.
    Lauhan CR; Schiff D; Gloude N
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28528. PubMed ID: 32776434
    [No Abstract]   [Full Text] [Related]  

  • 12. Incidence, clinical findings, and survival of hepatosplenic T-cell lymphoma in the United States.
    Durani U; Go RS
    Am J Hematol; 2017 Jun; 92(6):E99-E101. PubMed ID: 28263402
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatosplenic T-cell lymphoma: sinusoidal localization of malignant T-cells--a case report.
    Kakkar N; Banerjee AK; Marwaha N; Deodhar SD
    Am J Hematol; 1996 Dec; 53(4):278-9. PubMed ID: 8948673
    [No Abstract]   [Full Text] [Related]  

  • 14. Managing hepatosplenic gammadelta T-cell leukemia-lymphoma in children.
    Lo Nigro L; Munda S; Poli A; Licciardello M; D'Amico S; Di Cataldo A
    Pediatr Blood Cancer; 2007 Oct; 49(5):763. PubMed ID: 17120239
    [No Abstract]   [Full Text] [Related]  

  • 15. [Splenic pathology. Case no. 3. Hepatosplenic gammadelta T-cell lymphoma].
    de Mascarel A
    Ann Pathol; 2010 Jun; 30(3):211-5. PubMed ID: 20621599
    [No Abstract]   [Full Text] [Related]  

  • 16. Fulminant liver failure induced by hepatosplenic alphabeta T-cell lymphoma.
    Petersen-Benz C; Hoffmann N; Beckurts T; Goeser T; Steffen HM; Dries V
    Z Gastroenterol; 2003 Nov; 41(11):1083-6. PubMed ID: 14648377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatosplenic γδ T-cell lymphoma: an overview.
    Visnyei K; Grossbard ML; Shapira I
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):360-9. PubMed ID: 23876844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatosplenic γ-δ T-Cell Lymphoma: Who Is on Your Speed Dial?
    Krishnan M; Lunning M
    J Oncol Pract; 2019 Jun; 15(6):307-312. PubMed ID: 31185190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ring chromosome 7 with amplification of 7q sequences in a pediatric case of hepatosplenic T-cell lymphoma.
    Shetty S; Mansoor A; Roland B
    Cancer Genet Cytogenet; 2006 Jun; 167(2):161-3. PubMed ID: 16737917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-versus-lymphoma effect in progressive hepatosplenic gamma/delta T-cell lymphoma.
    He S; Roberts A; Ritchie D; Grigg A
    Leuk Lymphoma; 2007 Jul; 48(7):1448-50. PubMed ID: 17613781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.